奧美拉唑雜質(zhì)E1;埃索美拉唑雜質(zhì)E
|
PCL-#-Es049-25mg
|
≥95% 雜質(zhì)對照品 |
142885-92-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
奧美拉唑雜質(zhì)K;埃索美拉唑雜質(zhì)K
|
PCL-#-Es048-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Es048-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
奧美拉唑雜質(zhì)K;埃索美拉唑雜質(zhì)K
|
PCL-#-Es048-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Es048-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
奧美拉唑雜質(zhì)22
|
PCL-#-Es037-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Es037-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
奧美拉唑雜質(zhì)22
|
PCL-#-Es037-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Es037-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
阿達帕林雜質(zhì)A;2-(1-金剛烷基)-4-溴苯甲醚
|
PCL-#-Br109-50mg
|
≥95% 雜質(zhì)對照品 |
104224-63-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
阿達帕林雜質(zhì)A;2-(1-金剛烷基)-4-溴苯甲醚
|
PCL-#-Br109-25mg
|
≥95% 雜質(zhì)對照品 |
104224-63-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
多奈哌齊雜質(zhì) 3;多奈哌齊雜質(zhì) F
|
PCL-#-Be356-50mg
|
≥95% 雜質(zhì)對照品 |
1023500-88-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
多奈哌齊雜質(zhì) 3;多奈哌齊雜質(zhì) F
|
PCL-#-Be356-25mg
|
≥95% 雜質(zhì)對照品 |
1023500-88-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
阿奇霉素雜質(zhì)F
|
PCL-#-Az537-50mg
|
≥95%,雜質(zhì)對照品 |
612069-28-0 |
50mg
|
¥ 3500.0
|
1-2周 |
PCL |
阿奇霉素雜質(zhì)F
|
PCL-#-Az537-25mg
|
≥95% 雜質(zhì)對照品 |
612069-28-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
阿立哌唑溴代雜質(zhì)
|
PCL-#-Ar126-50mg
|
≥95% 雜質(zhì)對照品 |
203395-59-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
阿立哌唑溴代雜質(zhì)
|
PCL-#-Ar126-25mg
|
≥95% 雜質(zhì)對照品 |
203395-59-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
7-(4-溴丁氧基)-(1H)-喹啉-2-酮
|
PCL-#-Ah043-50mg
|
≥95% 雜質(zhì)對照品 |
1235403-62-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
7-(4-溴丁氧基)-(1H)-喹啉-2-酮
|
PCL-#-Ah043-25mg
|
≥95% ,雜質(zhì)對照品 |
1235403-62-9 |
25mg
|
¥ 800.0
|
3-5天 |
PCL |
沃替西汀雜質(zhì)N ;氫溴酸沃替西汀雜質(zhì)N;沃替西汀雜質(zhì)18
|
PCL-#-Vo291-50mg
|
≥95% 雜質(zhì)對照品 |
13616-83-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
沃替西汀雜質(zhì)N ;氫溴酸沃替西汀雜質(zhì)N;沃替西汀雜質(zhì)18
|
PCL-#-Vo291-25mg
|
≥95% 雜質(zhì)對照品 |
13616-83-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
阿達帕林雜質(zhì)C ;6-[3-(1-金剛烷基)-4-甲氧基苯基]-2-萘甲酸甲酯
|
PCL-#-Me132-50mg
|
≥95% 雜質(zhì)對照品 |
106685-41-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
阿達帕林雜質(zhì)C ;6-[3-(1-金剛烷基)-4-甲氧基苯基]-2-萘甲酸甲酯
|
PCL-#-Me132-25mg
|
≥95% 雜質(zhì)對照品 |
106685-41-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
奧美拉唑ep雜質(zhì)F AND G
|
PCL-#-Me098-50mg
|
≥95%,雜質(zhì)對照品 |
125656-82-8/125656-83-9 |
50mg
|
¥ 1000.0
|
1-2周 |
PCL |
奧美拉唑ep雜質(zhì)F AND G
|
PCL-#-Me098-25mg
|
≥95% 雜質(zhì)對照品 |
125656-82-8/125656-83-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
依托咪酯雜質(zhì)H
|
PCL-#-Ei100-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Ei100-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
依托咪酯雜質(zhì)H
|
PCL-#-Ei100-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Ei100-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
泊沙康唑中間體10
|
PCL-#-Et041-50mg
|
≥95% 雜質(zhì)對照品 |
184177-83-1 |
50mg
|
咨詢
|
咨詢 |
PCL |